Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Molibresib

Catalog No. T1906Cas No. 1260907-17-2
Alias I-BET 762, GSK525762, GSK 525762A

Molibresib (GSK525762) is an inhibitor of BET proteins (IC50: about 35 nM).

Molibresib

Molibresib

Purity: 99.08%
Catalog No. T1906Alias I-BET 762, GSK525762, GSK 525762ACas No. 1260907-17-2
Molibresib (GSK525762) is an inhibitor of BET proteins (IC50: about 35 nM).
Pack SizePriceAvailabilityQuantity
1 mg$36In Stock
2 mg$52In Stock
5 mg$85In Stock
10 mg$127In Stock
25 mg$228In Stock
50 mg$377In Stock
100 mg$563In Stock
200 mg$792In Stock
500 mg$1,230In Stock
1 mL x 10 mM (in DMSO)$94In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Molibresib"

Select Batch
Purity:99.08%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Molibresib (GSK525762) is an inhibitor of BET proteins (IC50: about 35 nM).
Targets&IC50
BET proteins:35 nM
In vitro
At day 2 of differentiation, I-BET-762 treatment altered cytokine production in CD4+ T cells, up-regulating the expression of some anti-inflammatory gene products and down-regulating the expression of some pro-inflammatory cytokines.I-BET-762 inhibited the binding of bromodomain and additional terminal domain proteins and BRD2/3/4 to the tandem bromodomain of the BET (Kd: 50.5-61.3 nM). In FRET analysis, displacement of the BET tandem bromodomain a tetraacetylated H4 peptide (IC50: 32.5-42.5 nM).
In vivo
At day 2 of differentiation, I-BET-762 treatment altered cytokine production in CD4+ T cells, up-regulating the expression of some anti-inflammatory gene products and down-regulating the expression of some pro-inflammatory cytokines.I-BET-762 inhibited the binding of bromodomain and additional terminal domain proteins and BRD2/3/4 to the tandem bromodomain of the BET (Kd: 50.5-61.3 nM). In FRET analysis, displacement of the BET tandem bromodomain a tetraacetylated H4 peptide (IC50: 32.5-42.5 nM).
Kinase Assay
Fluorescence resonance energy transfer (FRET) titrations: Fluorescence resonance energy transfer (FRET) titrations. I-BET is titrated against BRD2 (200 nM), BRD3 (100 nM) and BRD4 (50 nM) in 50 mM HEPES pH7.5, 50 mM NaCl, 0.5 mM CHAPS in the presence of tetra-acetylated Histone H4 peptide (200 nM). After equilibrating for 1 hour, the bromodomain protein : peptide interaction is detected using FRET following the addition of 2 nM Europium cryptate labelled streptavidin and 10 nM XL-665-labelled anti-6His antibody in assay buffer containing 0.05% (v/v) BSA and 400 mM KF. Plates are read using an Envision Plate reader (excitation 320 nm, emission 615 nm and 665 nm).
Cell Research
CD4+ T cells are isolated from lymph nodes and spleens of 10- to 12-wk old mice and activated with plate bound anti-CD3 and anti-CD28 antibodies in the presence of indicated cytokines. I-BET-762 compounds is included during the 60–72 h of initial activation. Over the course of 5 d of T-cell culture and expansion, the compounds is diluted 12-fold relative to the starting concentrations.(Only for Reference)
AliasI-BET 762, GSK525762, GSK 525762A
Chemical Properties
Molecular Weight423.9
FormulaC22H22ClN5O2
Cas No.1260907-17-2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: 39 mg/mL (92 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 60 mg/mL (141.54 mM)
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.3590 mL11.7952 mL23.5905 mL117.9523 mL
5 mM0.4718 mL2.3590 mL4.7181 mL23.5905 mL
10 mM0.2359 mL1.1795 mL2.3590 mL11.7952 mL
20 mM0.1180 mL0.5898 mL1.1795 mL5.8976 mL
50 mM0.0472 mL0.2359 mL0.4718 mL2.3590 mL
DMSO
1mg5mg10mg50mg
100 mM0.0236 mL0.1180 mL0.2359 mL1.1795 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Molibresib | purchase Molibresib | Molibresib cost | order Molibresib | Molibresib chemical structure | Molibresib in vivo | Molibresib in vitro | Molibresib formula | Molibresib molecular weight